Editorials |
From the Division of Respiratory, Critical Care and Occupational Pulmonary Medicine (K.A.S., J.R.H.), University of Utah Health Sciences Center and Veterans Affairs Medical Center, Salt Lake City.
Correspondence to John R. Hoidal, Department of Medicine. University of Utah Medical Center, 26 North 1900 East, Salt Lake City, UT 84132. E-mail John.Hoidal@hsc.utah.edu
See related article, pages 258–267
Key Words: NOX4 NADPH oxidase hypoxia pulmonary hypertension
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Chronic pulmonary arterial hypertension (PAH) is a devastating clinical disorder that contributes to the morbidity and mortality of adult and pediatric patients with a wide range of lung and heart diseases. Diseases leading to pulmonary hypertension are frequently associated with hypoxia within discrete areas of the lung. Acutely, the regional response to hypoxia is a reversible contraction of pulmonary artery smooth muscle cells (PASMC), which is a protective physiologic response that serves to redirect blood to better-ventilated areas of the lung. This constrictor response of PASMC contrasts with that of systemic arterial smooth muscle cells, which usually relax in response to hypoxia, indicating that oxygen (O2) sensing mechanisms in vascular smooth muscle are adapted to the environment from which they are derived. Importantly, chronic hypoxia induces irreversible changes of profound vascular remodeling characterized by medial and adventitial thickening of the muscular and elastic vessels and muscularization of previously nonmuscularized more distal small vessels. This is the basis for debilitating persistent PAH.1
Reactive oxygen species (ROS) are important regulators of vascular tone and function.2,3 In the lung, ROS are implicated in acute hypoxic vasoconstriction.4 Administration of superoxide dismutase significantly attenuates pulmonary vasoconstriction because of hypoxia.5 Moreover, several studies have now shown that agents promoting ROS generation stimulate both systemic arterial smooth muscle cells and PASMC proliferation implicating ROS in the vascular remodeling associated with chronic hypoxia. Again, suppression of endogenous ROS production inhibits smooth muscle cell (SMC) proliferation and promotes apoptosis.6–8 In animal models, ROS production has been directly linked
Related Article:
Circ. Res. 2007 101: 258-267.
This article has been cited by other articles:
![]() |
K. E. Dennis, J. L. Aschner, D. Milatovic, J. W. Schmidt, M. Aschner, M. R. Kaplowitz, Y. Zhang, and C. D. Fike NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L596 - L607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Fike, J. C. Slaughter, M. R. Kaplowitz, Y. Zhang, and J. L. Aschner Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L881 - L888. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nozik-Grayck, H. B. Suliman, S. Majka, J. Albietz, Z. Van Rheen, K. Roush, and K. R. Stenmark Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L422 - L430. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |